Strategies for cancer stem cell elimination: insights from mathematical modeling
- PMID: 22210402
- DOI: 10.1016/j.jtbi.2011.12.016
Strategies for cancer stem cell elimination: insights from mathematical modeling
Abstract
The cancer stem cell (CSC) hypothesis states that only a small fraction of a malignant cell population is responsible for tumor growth and relapse. Understanding the relationships between CSC dynamics and cancer progression may contribute to improvements in cancer treatment. Analysis of a simple discrete mathematical model has suggested that homeostasis in developing tissues is governed by a "quorum sensing" control mechanism, in which stem cells differentiate or proliferate according to feedback they receive from neighboring cell populations. Further analysis of the same model has indicated that excessive stem cell proliferation leading to malignant transformation mainly results from altered sensitivity to such micro-environmental signals. Our aim in this work is to expand the analysis to the dynamics of established populations of cancer cells and to examine possible therapeutic avenues for eliminating CSCs. The proposed model considers two populations of cells: CSCs, which can divide indefinitely, and differentiated cancer cells, which do not divide and have a limited lifespan. We assume that total cell density has negative feedback on CSC proliferation and that high CSC density activates CSC differentiation. We show that neither stimulation of CSC differentiation nor inhibition of CSC proliferation alone is sufficient for complete CSC elimination and cancer cure, since each of these two therapies affects a different subpopulation of CSCs. However, a combination of these two strategies can substantially reduce the population sizes and densities of all types of cancer cells. Therefore, we propose that in clinical trials, CSC differentiation therapy should only be examined in combination with chemotherapy. Our conclusions are corroborated by clinical experience with differentiating agents in acute promyelocytic leukemia and neuroblastoma.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?Bioessays. 2007 Dec;29(12):1269-80. doi: 10.1002/bies.20679. Bioessays. 2007. PMID: 18022789 Review.
-
Cancer stem cells and angiogenesis.Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Int J Dev Biol. 2011. PMID: 21732274 Review.
-
Die hard: are cancer stem cells the Bruce Willises of tumor biology?Cytometry A. 2009 Jan;75(1):67-74. doi: 10.1002/cyto.a.20690. Cytometry A. 2009. PMID: 19051297 Review.
-
Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.Cancer Lett. 2009 Dec 28;286(2):145-53. doi: 10.1016/j.canlet.2009.04.027. Epub 2009 May 22. Cancer Lett. 2009. PMID: 19464789 Review.
-
Cancer stem cells: lessons from leukemia.Trends Cell Biol. 2005 Sep;15(9):494-501. doi: 10.1016/j.tcb.2005.07.004. Trends Cell Biol. 2005. PMID: 16084092 Review.
Cited by
-
The depth of tumor hierarchy and its impact on hypertumor susceptibility.Sci Rep. 2025 Apr 3;15(1):11464. doi: 10.1038/s41598-025-94852-y. Sci Rep. 2025. PMID: 40181035 Free PMC article.
-
A mathematical model of cancer stem cell driven tumor initiation: implications of niche size and loss of homeostatic regulatory mechanisms.PLoS One. 2013 Aug 19;8(8):e71128. doi: 10.1371/journal.pone.0071128. eCollection 2013. PLoS One. 2013. PMID: 23990931 Free PMC article.
-
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.Front Immunol. 2024 Sep 30;15:1417201. doi: 10.3389/fimmu.2024.1417201. eCollection 2024. Front Immunol. 2024. PMID: 39403386 Free PMC article. Review.
-
Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts.PLoS One. 2014 Jan 9;9(1):e84654. doi: 10.1371/journal.pone.0084654. eCollection 2014. PLoS One. 2014. PMID: 24416258 Free PMC article.
-
In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.Cell Prolif. 2016 Jun;49(3):304-14. doi: 10.1111/cpr.12251. Epub 2016 Apr 15. Cell Prolif. 2016. PMID: 27079860 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources